Krishna Institute of Medical Sciences
KIMS •NSE

Krishna Institute of Medical Sciences

₹687.15-6.80 (0.98%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
678.80
Today’s high
695.75
52 week low
575.80
52 week high
858.00
Open price
694.30
Previous close
693.95
Live volume
4,73,382
Lower circuit
549.75
Upper circuit
824.55

Fundamentals

Market Cap
₹28,865Cr
ROE
10.74%
P/E Ratio(TTM)
148.43
EPS(TTM)
4.63
P/B Ratio
7.70
Dividend Yield
0.00%
Industry P/E
62.79
Book Value
89.22
Debt to Equity
1.89
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹1,196Cr
+10.29%
₹37.40Cr
+12.99%
03006009001.2k
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+36%
3Y CAGR+21%
Profit growthValue
1Y (TTM)-56%
3Y CAGR-13%

About

Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates a chain of multi-specialty hospitals in India.;
CEO/MD
Bhaskara Rao Bollineni
Founded in
1973
NSE symbol
KIMS

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹471.00
-12.25 (2.53%)
L
    H
    14,906.5780.517.36
    ₹1,230.70
    -40.00 (3.15%)
    L
      H
      12,500.8243.077.49
      ₹1,014.20
      -18.50 (1.79%)
      L
        H
        9,780.4556.055.49
        ₹638.75
        -18.85 (2.87%)
        L
          H
          9,537.42286.467.16
          Livesquawk •
          Krishna Institute Of Medical Sciences will acquire a 6% stake in Ushahkal Abhinav Specialty Hospital for ₹15 crore. The company aims to enhance operational efficiency through this acquisition by October 31, 2026.
          Livesquawk •
          KIMS denies reports of $52M stake acquisition talks with Renova Hospitals. The company stated no agreements or discussions have occurred.
          Livesquawk •
          KIMS issues 77,02,182 warrants to promoters for Rs. 150 crore funding. The funding is part of a planned capital raise by Krishna Institute of Medical Sciences.
          Livesquawk •
          KIMS plans to allocate future cash flows to greenfield expansion over debt repayment. The company targets a debt-to-equity ratio of approximately 2.5:1, per concall update.
          2026
          3
          Aug
          Quarterly Result
          Release date
          15
          May
          Quarterly & Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          7
          Nov
          Quarterly Result
          Release date
          6
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks